Michelle ChenCBO at Insilico MedicineSpeaker
Profile
Michelle Chen is the Chief Business Officer at Insilico Medicine, a leader in the AI-powered drug discovery and development field.
She is responsible for the company’s strategies, business and corporate development, and the US operations. As a biotech executive, Michelle brings in 20+ years of experience in biopharma and technology industries, having worked at multi-national companies such as Roche, Merck, BioMarin, Agilent, as well as small biotech companies. She has a strong track record of success in company building, BD&L, M&A, R&D, marketing, and product commercialization.
Michelle has a Ph.D. in Biochemistry from the University of Washington, did her postdoctoral work at UCSF, and received Bioinformatics training at Stanford.
Agenda Sessions
Pharma goes all in: the rise of artificial intelligence
, 15:30View Session